Argimón Pallàs Josep Maria, Riu Subirana Sebastià, Lizán Tudela Luis, Badia Llach Xavier, Martínez Lage José Manuel
Regió Sanitària Costa de Ponent, CatSalut, Barcelona, Spain.
Aten Primaria. 2007 Apr;39(4):171-7. doi: 10.1016/s0212-6567(07)70871-5.
To describe the initial treatment of patients >60 years who had subjective memory complaints and/or cognitive impairment for at least 6 months.
Observational, longitudinal, multicentre, and naturalistic study, with a follow-up period of 12 months.
A total of 105 primary care centres.
The study included 921 patients who attended a clinic.
In the baseline visit, the social demographic characteristics, diagnosis, treatment, and the health care referrals were recorded, and in the next 2 (6 and 12 months) the diagnostic change, treatment, and referrals.
The majority of subjects were female (66.9%) and the mean age was 74.3+/-6.8 years. In the initial visit, 50.5% (95% confidence interval [CI], 47.3-53.7) of the diagnoses were classed as syndromic and 33.3% (95% CI, 30.3-36.3), aetiological. The primary care doctor modified an unconfirmed initial diagnosis in 22% (95% CI, 19.3-24.7) of the patients during the 12 months follow-up study. A diagnosis was made in 63.8% (95% CI, 60.7-66.9) of patients by anamnesis, physical examination, the screening test, and laboratory data. In the initial visit, el 52.6% (95% CI, 49.4-55.8) received treatment of mainly nootropics and neuroprotectors, and later, the percentage of patients on cholinesterase inhibitors increased. The primary care doctor referred 54.9% (95% CI, 51.7-58.1) of the patients during the 12 months of the study.
The primary care doctor diagnoses the majority of patients with the means available, mainly based on anamnesis, examination, the screening test, and laboratory data. They prescribe drugs that lack efficacy for this disease and few of those that have been shown to be effective.
描述对年龄大于60岁、有主观记忆主诉和/或认知障碍至少6个月的患者的初始治疗情况。
观察性、纵向、多中心、自然主义研究,随访期为12个月。
共105个初级保健中心。
该研究纳入了921名到诊所就诊的患者。
在基线访视时,记录社会人口统计学特征、诊断、治疗及医疗转诊情况,在接下来的2次(6个月和12个月)访视中,记录诊断变化、治疗及转诊情况。
大多数受试者为女性(66.9%),平均年龄为74.3±6.8岁。在初次就诊时,50.5%(95%置信区间[CI],47.3 - 53.7)的诊断归类为综合征性诊断,33.3%(95%CI,30.3 - 36.3)为病因学诊断。在12个月的随访研究中,初级保健医生对22%(95%CI,19.3 - 24.7)的患者修改了未经证实的初始诊断。通过问诊、体格检查、筛查试验和实验室数据,63.8%(95%CI,60.7 - 66.9)的患者得到了诊断。在初次就诊时,52.6%(95%CI,49.4 - 55.8)的患者主要接受了促智药和神经保护剂治疗,后来,使用胆碱酯酶抑制剂的患者比例增加。在研究的12个月期间,初级保健医生转诊了54.9%(95%CI,51.7 - 58.1)的患者。
初级保健医生主要根据问诊、检查、筛查试验和实验室数据,利用现有手段诊断大多数患者。他们开出的药物对该疾病缺乏疗效,而被证明有效的药物使用较少。